Publications 2016 – 2014

| 2016 | 2015 | 2014 | 2013 thru 2010 | 2009 thru 2006 | 2005 thru 2001 |



  1. Shah K. Stem cell-based therapies for tumors in the brain: are we there yet? Neuro Oncol. 2016 Jun 9. pii: now096. PMID: 27282399


  1. Zhu, Y., Choi, S.H. and Shah, K. Receptor targeted antibodies for cancer therapy. Lancet Oncology. 2015; Nov;16(15):e543-54. doi: 10.1016/S1470-2045(15)00039-X. PMID: 26545843
  2. Bagci-Onder, T., Du, W., Figueiredo, Martinez-Quintanilla, J., and Shah, K. Targeting breast to brain metastatic tumors with death receptor ligand expressing therapeutic stem cells. BRAINDoi:10.1093/brain/awv094. PMID: 25910782
  3. Bhere, D.,Shah, K. Stem Cell-Based Therapies for Cancer. Cancer Res. 2015;127:159-89. doi: 10.1016/bs .acr.2015.04.012. Epub 2015 May 19. PMID: 26093900
  4. Wehrenberg-Klee, E., Redjal, N., Leece, A., Turker, N.S., Heidari, P.,Shah, K., Mahmood U.PET imaging of glioblastoma multiforme EGFR expression for therapeutic decision guidance.Am J Nucl Med Mol Imaging. 2015 Jun 15;5(4):379-89. PMID: 26269775
  5. Choi, SH., Tamura, K., Khajuria, R., Lawler, J., and Shah, K. Antiangiogenic variant of TSP-1 targets TRAIL resistance in brain tumors. Molecular Therapy. 2015, 23(2):235-43. doi: 10.1038/mt.2014.214. PMID: 25358253
  6. Redjal, N., Zhu, Y. and Shah, K. Combination of systemic chemotherapy with local stem cell delivered S-TRAIL in resected brain tumors. Stem Cells. 33(1):101-10. doi: 10.1002/stem.1834. PMID: 25186100


  1. Martinez-Quintanilla, J., Shah K. Response to “Stem cells loaded with multimechanistic oncolytic herpes simplex virus variants for brain tumor therapy.” J Natl Cancer Inst. 2014 Dec 2;107(1):370. doi: 10.1093/jnci/dju370. Print 2015 Jan. No abstract available. PMID: 25473105
  2. Stuckey, DW., and Shah, K. Therapeutic stem cells for cancer. Nature Reviews Cancer. 2014 Oct;14(10):683-91. doi: 10.1038/nrc3798. Epub 2014 Sep 1. PMID: 25176333.
  3. Sullivan, J.P., Nahed, B.V., Madden, M.W., Oliveira, S.M., Springer, S., Bhere, D., Chi, A.S., Wakimoto, H., Kapur,R., Shah, K., Iafrate, J.A.,, Curry, W.T., Loeffler, J.S., Batchelor, T.T., Louis, D.N., Toner, M., Maheswaran, S. and Haber, D.A. Brain Tumor Cells in Circulation Are Enriched for Mesenchymal Gene Expression.Cancer Discov. 2014 Aug 19. [Epub ahead of print]. PMID: 25139148
  4. Redjal, N., Zhu, Y. and Shah, K. Combining systemically delivered chemotherapy with encapsulated stem cell TRAIL in resected brain tumors. Stem Cells. 2014. Sep 3. doi: 10.1002/stem.1834. [Epub ahead of print]
  5. Srivastava, J., Robertson, CL., Rajasekaran, D., Gredler, R., Siddiq, A., Emdad, L., Mukhopadhyay, ND., Ghosh, S., Hylemon, PB., Gil, G., Bhere, D., Shah, K., Subler, MA., Windle, JJ., Fisher, PB and Sarkar, D. Astrocyte Elevated Gene-1(AEG-1) Contributes to Hepatocellular Carcinoma by Regulating Retinoid X Receptor (RXR). Cancer Research. 2014; 74: 4364-77. doi: 10.1158/0008-5472.
  6. Kuruppu D, Brownell Al, Shah K, Mahmood U, Tanabe kk. Molecular imaging with bioluminescence and PET reveals viral oncolysis kinetics and tumor viability. Cancer Res. 2014 May 29. pii: canres.3472.2013. [Epub ahead of print]. PMID: 24876106
  7. Shah, K. Mesenchymal Stem Cells in Cancer Therapy .Elsevier. 2014 January PMID: 21740940
  8. Duebgen, M., Martinez-Quintanilla, J., Tamura, K., Hingtgen, S., Redjal, N., Wakimoto, H and Shah, K. Stem Cells Loaded With Multimechanistic Oncolytic herpes simplex virus variants for brain tumor therapy. Journal of Nat. Canc. Inst. 2014. PMID: 24838834
  9. Du, W, Uslar, L., Sevala, S. and Shah, K. Targeting c-Met receptor overcomes TRAIL-resistance in brain tumors. PLoS One. 2014 Apr 18. PMID: 24748276
  10. Zhu, Y and Shah, K. Multiple lesions in receptor tyrosine kinase pathway determine glioblastoma response to pan-ERBB inhibitor PF-00299804 and PI3K/mTOR dual inhibitor PF-05212384. Cancer Biol Ther. 2014 March 25. PMID: 24658109